Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Septic Shock
NCT02883803Phase 2Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Dec 2019
- Primary completion
- Nov 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in septic shock, sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02883803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02883803.